×
For best experience we recommend to activate Javascript in your browser.
TR4 antibody (AA 1-241)
The Mouse Monoclonal anti-TR4 antibody (Clone OTI1B1) (ABIN2727567) specifically detects TR4 in WB and IHC.
The antibody is reactive with Human samples.
Catalog No. ABIN2727567
$608.40
Plus shipping costs $50.00
Delivery in 6 to 8 Business Days
Quick Overview for TR4 antibody (AA 1-241) (ABIN2727567)
Target
See all TR4 (NR2C2) Antibodies
TR4 (NR2C2)
(Nuclear Receptor Subfamily 2, Group C, Member 2 (NR2C2))
Reactivity
All reactivities for TR4 antibodies
Human
Host
All hosts for TR4 antibodies
Mouse
Clonality
All clonalities for TR4 antibodies
Monoclonal
Conjugate
All conjugates for TR4 antibodies
This TR4 antibody is un-conjugated
Application
All applications for TR4 antibodies
Western Blotting (WB), Immunohistochemistry (IHC)
Clone
OTI1B1
Product Details anti-TR4 Antibody
(hide)
Binding Specificity
All epitopes for TR4 antibodies
AA 1-241
Purification
Purified from mouse ascites fluids by affinity chromatography
Immunogen
Human recombinant protein fragment corresponding to amino acids 1-241 of human NR2C2(NP_003289) produced in E.coli.
Isotype
IgG1
Alternatives
(show)
anti-Nuclear Receptor Subfamily 2, Group C, Member 2 (NR2C2) (pThr184), (pThr187) antibody
NR2C2
Reactivity: Human, Rat, Mouse
WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro)
Host: Rabbit
Polyclonal
unconjugated
Application Details
(hide)
Application Notes
WB 1:2000, IHC 1:150,
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1.00 mg/mL
Target Details for TR4
(hide)
Target
TR4 (NR2C2)
(Nuclear Receptor Subfamily 2, Group C, Member 2 (NR2C2))
Alternative Name
NR2C2
Molecular Weight
67.2 kDa
NCBI Accession
NM_003298
HGNC
7182
Pathways
TCR Signaling , Nuclear Receptor Transcription Pathway , Steroid Hormone Mediated Signaling Pathway , Regulation of Leukocyte Mediated Immunity , Positive Regulation of Immune Effector Process , Production of Molecular Mediator of Immune Response , Tube Formation , Toll-Like Receptors Cascades
Recently viewed
(hide)
Chat with us , powered by LiveChat